Chronic Spontaneous Urticaria
2 competing products in clinical development for Chronic Spontaneous Urticaria.
Pipeline by Phase
Phase 1/21
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CT-P39 + EU-approved Xolair | Celltrion | Phase 3 | Completed | 77 |
| Briquilimab | Jasper Therapeutics | Phase 1/2 | Active | 33 |